SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Instagram Outage Disrupts Thousands of U.S. Users 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
-- Curriculum for healthcare providers now offers 13 AAFP Elective credits --
CHARLOTTESVILLE, Va., Oct. 27, 2017 -- TMCIGlobal (TMCI), a leading provider of online medical cannabis education, has received American Academy of Family Physicians (AAFP) CME credit for its, “Clinical Cannabinoid Medicine Curriculum.”
“TMCIGlobal is proud to offer both AAFP and CME credit for this curriculum,” said Vicky Mossman, VP of Partner Development. “Our science-based education offers continuing education to healthcare professionals in all specialties who want to learn more about the clinical application of medical cannabis. With family practitioners being a large part of the learner base for TMCI, we are pleased to see that the American Academy of Family Physicians finds the curriculum acceptable for credit.”
Developed in collaboration with the Society of Cannabis Clinicians (SCC), the Clinical Cannabinoid Medicine Curriculum covers the history of medical cannabis, cannabis ethnobotany, pharmacology and physiologic effects, as well as delivery and dosage. Clinical use for pain, immune disorders, neurodegenerative diseases, mental health conditions and cancer are also presented in this mobile-friendly, comprehensive curriculum.
The Clinical Cannabinoid Medicine Curriculum has been approved for 13 AAFP Elective credits. To learn more about the course, click here. Group pricing is available.
About TMCIGlobal
TMCIGlobal (TMCI) provides science-based, online medical education for healthcare professionals who want to learn about medical cannabis and its potential clinical application to deliver quality care and address patient questions. TMCI works with organizations that are recognized as pillars of medical cannabis learning and brings their valuable medical expertise to the healthcare community via an ever-growing online course catalog.
Media Contact: Danielle McNulty | 434-234-0009 | [email protected]
